Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Jun 15;376(24):2341-2348.
doi: 10.1056/NEJMoa1614835. Epub 2017 May 4.

Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome

Affiliations
Randomized Controlled Trial

Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome

Walter K Kraft et al. N Engl J Med. .

Abstract

Background: Current pharmacologic treatment of the neonatal abstinence syndrome with morphine is associated with a lengthy duration of therapy and hospitalization. Buprenorphine may be more effective than morphine for this indication.

Methods: In this single-site, double-blind, double-dummy clinical trial, we randomly assigned 63 term infants (≥37 weeks of gestation) who had been exposed to opioids in utero and who had signs of the neonatal abstinence syndrome to receive either sublingual buprenorphine or oral morphine. Infants with symptoms that were not controlled with the maximum dose of opioid were treated with adjunctive phenobarbital. The primary end point was the duration of treatment for symptoms of neonatal opioid withdrawal. Secondary clinical end points were the length of hospital stay, the percentage of infants who required supplemental treatment with phenobarbital, and safety.

Results: The median duration of treatment was significantly shorter with buprenorphine than with morphine (15 days vs. 28 days), as was the median length of hospital stay (21 days vs. 33 days) (P<0.001 for both comparisons). Adjunctive phenobarbital was administered in 5 of 33 infants (15%) in the buprenorphine group and in 7 of 30 infants (23%) in the morphine group (P=0.36). Rates of adverse events were similar in the two groups.

Conclusions: Among infants with the neonatal abstinence syndrome, treatment with sublingual buprenorphine resulted in a shorter duration of treatment and shorter length of hospital stay than treatment with oral morphine, with similar rates of adverse events. (Funded by the National Institute on Drug Abuse; BBORN ClinicalTrials.gov number, NCT01452789 .).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Enrollment and Outcomes.
Figure 2
Figure 2. Duration of Treatment and Length of Hospital Stay
The duration of treatment (Panel A) and length of hospital stay (Panel B) were shorter in the buprenorphine group than in the morphine group (P<0.001 for both comparisons). Randomization was stratified according to the type of intended feeding method (bottle-feeding or breast-feeding). The box-and-whisker plots represent medians (horizontal lines) and interquartile ranges (top and bottom of the boxes); the I bars represent the maximum or minimum value or 1.5 times the interquartile range. Outliers are indicated by circles.

Comment in

References

    1. Hudak ML, Tan RC. Neonatal drug withdrawal. Pediatrics. 2012;129(2):e540–e560. - PubMed
    1. Holmes AV, Atwood EC, Whalen B, et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics. 2016;137(6):e20152929. - PubMed
    1. Short VL, Gannon M, Abatemarco DJ. The association between breastfeeding and length of hospital stay among infants diagnosed with neonatal abstinence syndrome: a population-based study of in-hospital births. Breastfeed Med. 2016;11:343–9. - PubMed
    1. Patrick SW, Schumacher RE, Horbar JD, et al. Improving care for neonatal abstinence syndrome. Pediatrics. 2016;137(5):e20153835. - PMC - PubMed
    1. Osborn DA, Jeffery HE, Cole MJ. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev. 2010:CD002059. - PubMed

Publication types

MeSH terms

Associated data